Atlas Trials

The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting

Clinical trial NCT05772676 · UNKNOWN

Trial details

NCT number
NCT05772676
Sponsor
Hospital General Tlahuac
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
ObesityNausea and Vomiting, Postoperative
Start date
2022-12-01
Primary completion
2023-01-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.